WallStreetZenWallStreetZen

NYSE: RCUS
Arcus Biosciences Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

RCUS past revenue growth

How has RCUS's revenue growth performed historically?
Company
4.46%
Industry
145.73%
Market
17.2%
RCUS's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
RCUS's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
RCUS's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

RCUS earnings and revenue history

Current Revenue
$117.0M
Current Earnings
-$307.0M
Current Profit Margin
-262.4%

RCUS Return on Equity

Current Company
-57.2%
Current Industry
-63.5%
Current Market
188%
RCUS's Return on Equity (-57.2%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when RCUS announces earnings.

RCUS Return on Assets

Current Company
-25.8%
Current Industry
2.9%
RCUS is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

RCUS Return on Capital Employed

Current Company
-33.04%
Current Industry
19.5%
RCUS's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

RCUS vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
RCUS$117.00M-$285.00M-$307.00M+69.54%N/A
GYRE$113.45M-$82.99M-$92.93M+164.06%N/A
MORF$0.00-$159.71M-$161.25M-100.00%N/A
KNSA$301.77M-$16.36M$8.65M+106.55%-95.74%
LGNDN/AN/AN/AN/AN/A
View Top Biotech Stocks

RCUS earnings dates

Next earnings date
Jun 6, 2024

Arcus Biosciences Earnings & Revenue FAQ

What were RCUS's earnings last quarter?

On Invalid Date, Arcus Biosciences (NYSE: RCUS) reported Q4 2023 earnings per share (EPS) of -$1.08, up 16.13% year over year. Total Arcus Biosciences earnings for the quarter were -$81.00 million. In the same quarter last year, Arcus Biosciences's earnings per share (EPS) was -$0.93.

If you're new to stock investing, here's how to buy Arcus Biosciences stock.

What was RCUS's earnings growth in the past year?

As of Q2 2024, Arcus Biosciences's earnings has grown year over year. Arcus Biosciences's earnings in the past year totalled -$307.00 million.

What is RCUS's earnings date?

Arcus Biosciences's earnings date is Invalid Date. Add RCUS to your watchlist to be reminded of RCUS's next earnings announcement.

What was RCUS's revenue last quarter?

On Invalid Date, Arcus Biosciences (NYSE: RCUS) reported Q4 2023 revenue of $31.00 million up 8.82% year over year. In the same quarter last year, Arcus Biosciences's revenue was $34.00 million.

What was RCUS's revenue growth in the past year?

As of Q2 2024, Arcus Biosciences's revenue has grown 4.46% year over year. This is 141.27 percentage points lower than the US Biotechnology industry revenue growth rate of 145.73%. Arcus Biosciences's revenue in the past year totalled $117.00 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.